Effects of catecholic tetrahydroisoquinolines on endogenous catecholamines.
D000818:Animals; D001545:Benserazide / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism*; D002396:Catechols / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D007546:Isoquinolines / Q000494:pharmacology*; D007980:Levodopa / Q000378:metabolism; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D012490:Salsoline Alkaloids / Q000494:pharmacology; D013765:Tetrahydropapaveroline / Q000494:pharmacology
D002395:Catecholamines; D002396:Catechols; D007546:Isoquinolines; D012490:Salsoline Alkaloids; D007980:Levodopa; D013765:Tetrahydropapaveroline; D001545:Benserazide; D004298:Dopamine; D009638:Norepinephrine